Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Robers

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Medicinal Chemistry|May 21, 2022
Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffoldZhengnian Li, Ryosuke Ishida, Yan Liu, et al.
Molecular Cancer Therapeutics|December 17, 2014
Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological inductionRenata Jaskula-Sztul, Jacob Eide, Sara Tesfazghi, et al.
Nature Chemical Biology|March 22, 2022
KRAS is vulnerable to reversible switch-II pocket engagement in cellsJames D Vasta, D Matthew Peacock, Qinheng Zheng, et al.
Journal of Medicinal Chemistry|April 8, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse ModelSida Shen, Cristina Picci, Kseniya Ustinova, et al.
Biochemical Pharmacology|April 11, 2017
Real-time analysis of the binding of fluorescent VEGF<sub>165</sub>a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexesLaura E Kilpatrick, Rachel Friedman-Ohana, Diana C Alcobia, et al.
ACS Chemical Neuroscience|December 5, 2018
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X SyndromeAlan P Kozikowski, Sida Shen, Marta Pardo, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function VariantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Frontiers in Chemical Biology|April 20, 2026
Development of SYK NanoBRET cellular target engagement assays for gain-of-function variantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Nature Chemical Biology|October 27, 2022
Small-molecule inhibition of the archetypal UbiB protein COQ8Nathan H Murray, Christopher R M Asquith, Zixiang Fang, et al.
Cell Chemical Biology|July 25, 2023
DELs enable the development of BRET probes for target engagement studies in cellsKelly A Teske, Wenji Su, Cesear R Corona, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|May 21, 2022
Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffoldZhengnian Li, Ryosuke Ishida, Yan Liu, et al.
Molecular Cancer Therapeutics|December 17, 2014
Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological inductionRenata Jaskula-Sztul, Jacob Eide, Sara Tesfazghi, et al.
Nature Chemical Biology|March 22, 2022
KRAS is vulnerable to reversible switch-II pocket engagement in cellsJames D Vasta, D Matthew Peacock, Qinheng Zheng, et al.
Journal of Medicinal Chemistry|April 8, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse ModelSida Shen, Cristina Picci, Kseniya Ustinova, et al.
Biochemical Pharmacology|April 11, 2017
Real-time analysis of the binding of fluorescent VEGF<sub>165</sub>a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexesLaura E Kilpatrick, Rachel Friedman-Ohana, Diana C Alcobia, et al.
ACS Chemical Neuroscience|December 5, 2018
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X SyndromeAlan P Kozikowski, Sida Shen, Marta Pardo, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function VariantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Frontiers in Chemical Biology|April 20, 2026
Development of SYK NanoBRET cellular target engagement assays for gain-of-function variantsJacob L Capener, James D Vasta, Vittorio L Katis, et al.
Nature Chemical Biology|October 27, 2022
Small-molecule inhibition of the archetypal UbiB protein COQ8Nathan H Murray, Christopher R M Asquith, Zixiang Fang, et al.
Cell Chemical Biology|July 25, 2023
DELs enable the development of BRET probes for target engagement studies in cellsKelly A Teske, Wenji Su, Cesear R Corona, et al.
Pageof 7